Compare Dai (DAI) vs Enzyme (MLN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dai vs Enzyme — how do they compare? Dai trades at Rp17,251 (market cap Rp92,41T, Rp1,28T 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: Dai is far larger — about 688958.5× Enzyme's market cap, and Dai's circulating supply is 5,4B DAI versus 3,3M MLN for Enzyme. Which is the better fit depends on your goals — on Pluang, investors hold Dai for 31 Days and Enzyme for 29 Days on average.
| DAI | MLN | |
|---|---|---|
Market Cap | Rp92,41T | Rp134,13M |
Volume (24h) | Rp1,28T | Rp104,56M |
Circulating Supply | 5,4B DAI | 3,3M MLN |
Typical Hold Time | 31 Days | 29 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Dai maintains a substantial market cap of Rp92,41T with 5,4M tokens in circulation, indicating significant adoption as a stablecoin. The 31-day average hold time suggests stable usage patterns. Technical analysis shows consistent stability within its peg range, with trading volumes reflecting steady demand. Recent ecosystem developments include ongoing protocol optimizations to maintain the USD peg through collateralized debt positions.
Overall outlook remains stable given Dai's proven track record as a decentralized stablecoin. Key opportunities include continued DeFi adoption and cross-chain expansion. Major risks include regulatory scrutiny of stablecoins and potential collateral volatility. Investors should monitor MakerDAO governance decisions and overall DeFi market health.
Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.
Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.
About Dai
DAI is an Ethereum-based stablecoin managed by the Maker Protocol and MakerDAO. Its value is soft-pegged to the U.S. dollar and backed by various cryptocurrencies stored in smart contract vaults. DAI provides a decentralized way to hold a stable digital asset, with options like Multi-Collateral DAI for flexible backing and the DAI Savings Rate for earning interest.
Read more on DAI →About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →
